Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 10242 | 47.01 |
09:34 ET | 1044 | 46.82 |
09:36 ET | 1539 | 46.91 |
09:38 ET | 1007 | 46.93 |
09:39 ET | 2487 | 46.645 |
09:41 ET | 2499 | 47.075 |
09:43 ET | 692 | 47.06 |
09:45 ET | 896 | 46.98 |
09:48 ET | 2127 | 47.0124 |
09:50 ET | 1722 | 46.995 |
09:52 ET | 200 | 46.97 |
09:54 ET | 4895 | 47.54 |
09:56 ET | 1300 | 47.53 |
09:57 ET | 780 | 47.52 |
09:59 ET | 952 | 47.34 |
10:01 ET | 950 | 47.66 |
10:03 ET | 1044 | 47.51 |
10:06 ET | 100 | 47.49 |
10:08 ET | 970 | 47.59 |
10:10 ET | 900 | 47.78 |
10:12 ET | 300 | 47.72 |
10:14 ET | 2649 | 47.8 |
10:15 ET | 1627 | 47.87 |
10:17 ET | 4703 | 47.87 |
10:19 ET | 3323 | 47.76 |
10:21 ET | 400 | 47.8 |
10:24 ET | 1747 | 47.98 |
10:26 ET | 1041 | 47.87 |
10:28 ET | 733 | 47.825 |
10:30 ET | 2459 | 47.89 |
10:32 ET | 2925 | 47.91 |
10:33 ET | 1577 | 47.9 |
10:35 ET | 5904 | 47.75 |
10:37 ET | 4459 | 48.1 |
10:39 ET | 2966 | 48.29 |
10:42 ET | 1233 | 48.3 |
10:44 ET | 6258 | 48.28 |
10:46 ET | 2284 | 48.09 |
10:48 ET | 700 | 47.95 |
10:50 ET | 100 | 47.91 |
10:51 ET | 200 | 47.895 |
10:53 ET | 600 | 47.82 |
10:55 ET | 2020 | 47.8597 |
10:57 ET | 500 | 47.79 |
11:00 ET | 2562 | 47.86 |
11:02 ET | 2271 | 47.945 |
11:04 ET | 400 | 47.96 |
11:06 ET | 793 | 47.82 |
11:08 ET | 200 | 47.71 |
11:09 ET | 104 | 47.69 |
11:11 ET | 215 | 47.7 |
11:13 ET | 2278 | 47.84 |
11:15 ET | 1840 | 47.95 |
11:18 ET | 900 | 48 |
11:20 ET | 737 | 47.945 |
11:22 ET | 200 | 47.95 |
11:24 ET | 7255 | 47.94 |
11:26 ET | 2100 | 47.88 |
11:27 ET | 2195 | 47.89 |
11:29 ET | 1084 | 47.87 |
11:31 ET | 1380 | 48.005 |
11:33 ET | 1200 | 47.845 |
11:36 ET | 2520 | 47.75 |
11:38 ET | 275 | 47.78 |
11:40 ET | 1254 | 47.84 |
11:42 ET | 1125 | 47.85 |
11:44 ET | 1369 | 48.03 |
11:45 ET | 2855 | 48.0375 |
11:47 ET | 100 | 48.05 |
11:49 ET | 4534 | 48.28 |
11:51 ET | 100 | 48.25 |
11:54 ET | 1389 | 48.38 |
11:56 ET | 2569 | 48.3992 |
11:58 ET | 3971 | 48.5 |
12:00 ET | 3880 | 48.4687 |
12:02 ET | 8374 | 48.575 |
12:03 ET | 4050 | 48.45 |
12:05 ET | 1809 | 48.515 |
12:07 ET | 1546 | 48.58 |
12:09 ET | 4090 | 48.56 |
12:12 ET | 600 | 48.54 |
12:14 ET | 800 | 48.58 |
12:16 ET | 350 | 48.58 |
12:18 ET | 1300 | 48.59 |
12:20 ET | 1877 | 48.5949 |
12:21 ET | 12620 | 48.545 |
12:25 ET | 828 | 48.63 |
12:27 ET | 159 | 48.59 |
12:30 ET | 3150 | 48.76 |
12:32 ET | 1528 | 48.68 |
12:34 ET | 1878 | 48.88 |
12:36 ET | 995 | 48.76 |
12:38 ET | 665 | 48.745 |
12:39 ET | 1964 | 48.83 |
12:41 ET | 700 | 48.72 |
12:45 ET | 1420 | 48.86 |
12:48 ET | 2295 | 48.785 |
12:50 ET | 900 | 48.72 |
12:52 ET | 8727 | 48.82 |
12:54 ET | 927 | 48.8 |
12:56 ET | 1800 | 48.8 |
12:57 ET | 4730 | 48.93 |
12:59 ET | 700 | 48.98 |
01:01 ET | 2449 | 48.87 |
01:03 ET | 1500 | 48.945 |
01:06 ET | 527 | 48.945 |
01:08 ET | 2984 | 48.97 |
01:10 ET | 10373 | 49 |
01:12 ET | 2500 | 49.045 |
01:14 ET | 3070 | 48.92 |
01:15 ET | 500 | 48.94 |
01:17 ET | 1669 | 48.82 |
01:19 ET | 1077 | 48.76 |
01:21 ET | 600 | 48.76 |
01:24 ET | 1419 | 48.78 |
01:26 ET | 1100 | 48.93 |
01:28 ET | 800 | 48.8 |
01:30 ET | 900 | 48.86 |
01:32 ET | 305 | 48.815 |
01:33 ET | 300 | 48.825 |
01:35 ET | 12340 | 48.77 |
01:37 ET | 2458 | 48.69 |
01:39 ET | 100 | 48.675 |
01:42 ET | 17765 | 48.675 |
01:44 ET | 1527 | 48.74 |
01:46 ET | 10725 | 48.59 |
01:48 ET | 16100 | 48.75 |
01:50 ET | 1100 | 48.855 |
01:51 ET | 2832 | 48.89 |
01:53 ET | 850 | 48.89 |
01:55 ET | 2840 | 48.99 |
01:57 ET | 700 | 48.98 |
02:00 ET | 1412 | 48.77 |
02:02 ET | 1165 | 48.91 |
02:06 ET | 400 | 48.84 |
02:08 ET | 100 | 48.83 |
02:09 ET | 600 | 48.8 |
02:11 ET | 1800 | 48.67 |
02:13 ET | 615 | 48.7283 |
02:15 ET | 1200 | 48.72 |
02:18 ET | 1630 | 48.79 |
02:20 ET | 110 | 48.7789 |
02:22 ET | 400 | 48.795 |
02:24 ET | 1123 | 48.75 |
02:26 ET | 500 | 48.77 |
02:27 ET | 2000 | 48.64 |
02:31 ET | 19598 | 48.2 |
02:33 ET | 1647 | 48.14 |
02:36 ET | 1123 | 48.36 |
02:38 ET | 400 | 48.4 |
02:40 ET | 595 | 48.43 |
02:42 ET | 205 | 48.39 |
02:44 ET | 500 | 48.62 |
02:45 ET | 1096 | 48.49 |
02:47 ET | 2700 | 48.3 |
02:49 ET | 5223 | 48.305 |
02:51 ET | 906 | 48.375 |
02:54 ET | 1101 | 48.426 |
02:56 ET | 2661 | 48.48 |
02:58 ET | 2054 | 48.5225 |
03:00 ET | 1927 | 48.53 |
03:02 ET | 26973 | 48.16 |
03:03 ET | 18352 | 48.61 |
03:05 ET | 3217 | 48.62 |
03:07 ET | 2307 | 48.62 |
03:09 ET | 577 | 48.67 |
03:12 ET | 1000 | 48.62 |
03:14 ET | 1386 | 48.54 |
03:16 ET | 2921 | 48.65 |
03:18 ET | 1137 | 48.645 |
03:20 ET | 2217 | 48.6 |
03:21 ET | 4950 | 48.56 |
03:23 ET | 26854 | 48.52 |
03:25 ET | 3317 | 48.62 |
03:27 ET | 1432 | 48.615 |
03:30 ET | 3874 | 48.58 |
03:32 ET | 2400 | 48.76 |
03:34 ET | 1512 | 48.81 |
03:36 ET | 2760 | 48.88 |
03:38 ET | 4899 | 48.86 |
03:39 ET | 3990 | 49 |
03:41 ET | 2457 | 48.91 |
03:43 ET | 4360 | 48.94 |
03:45 ET | 7020 | 48.83 |
03:48 ET | 4072 | 48.8 |
03:50 ET | 6252 | 48.74 |
03:52 ET | 9406 | 48.7 |
03:54 ET | 9120 | 48.88 |
03:56 ET | 14591 | 48.84 |
03:57 ET | 88302 | 48.66 |
03:59 ET | 255549 | 48.83 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.1B | -7.7x | --- |
Intellia Therapeutics Inc | 2.1B | -4.3x | --- |
Vera Therapeutics Inc | 2.1B | -20.2x | --- |
Recursion Pharmaceuticals Inc | 2.0B | -5.6x | --- |
Geron Corp | 2.1B | -11.5x | --- |
Celldex Therapeutics Inc | 2.2B | -11.6x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -7.7x |
Price/Sales (TTM) | 70.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.